Cargando…
Liver Fibrosis Assessment with Diffusion-Weighted Imaging: Value of Liver Apparent Diffusion Coefficient Normalization Using the Spleen as a Reference Organ
Liver fibrosis staging is of great clinical importance because it is used to assess the severity of the underlying chronic liver disease. Among various imaging-based methods, apparent diffusion coefficient (ADC) measurement using diffusion-weighted imaging (DWI) has the potential to be used as an im...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787628/ https://www.ncbi.nlm.nih.gov/pubmed/31466404 http://dx.doi.org/10.3390/diagnostics9030107 |
_version_ | 1783458308971036672 |
---|---|
author | Shin, Min Ki Song, Ji Soo Hwang, Seung Bae Hwang, Hong Pil Kim, Young Jun Moon, Woo Sung |
author_facet | Shin, Min Ki Song, Ji Soo Hwang, Seung Bae Hwang, Hong Pil Kim, Young Jun Moon, Woo Sung |
author_sort | Shin, Min Ki |
collection | PubMed |
description | Liver fibrosis staging is of great clinical importance because it is used to assess the severity of the underlying chronic liver disease. Among various imaging-based methods, apparent diffusion coefficient (ADC) measurement using diffusion-weighted imaging (DWI) has the potential to be used as an imaging biomarker for liver fibrosis assessment. In this study, we investigated the usefulness of liver ADC normalization using the spleen as a reference organ in liver fibrosis staging with 66 patients who underwent liver magnetic resonance imaging (MRI), transient elastography (TE), and surgical resection of a hepatic mass. ADC values of the liver (ADC(liver)) and spleen were analyzed, and the spleen was used for ADC(liver) normalization (nADC(liver)). ADC(liver) showed a weak negative correlation with TE (r = −0.246; p = 0.047) and fibrosis stage (r = −0.269; p = 0.029), while n ADC(liver) showed a moderate negative correlation with TE (r = −0.504; p < 0.001) and fibrosis stage (r = −0.579; p < 0.001). AUC values for nADC(liver) (0.777–0.875) were higher than those for ADC(liver) for each stage of fibrosis (0.596–0.713, p = 0.037–0.157). AUC values for TE (0.726–0.884) and nADC(liver) were not statistically different. In conclusion, normalized liver ADC can be useful in diagnosing liver fibrosis stage in patients with variable DWI acquisitions. |
format | Online Article Text |
id | pubmed-6787628 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67876282019-10-16 Liver Fibrosis Assessment with Diffusion-Weighted Imaging: Value of Liver Apparent Diffusion Coefficient Normalization Using the Spleen as a Reference Organ Shin, Min Ki Song, Ji Soo Hwang, Seung Bae Hwang, Hong Pil Kim, Young Jun Moon, Woo Sung Diagnostics (Basel) Article Liver fibrosis staging is of great clinical importance because it is used to assess the severity of the underlying chronic liver disease. Among various imaging-based methods, apparent diffusion coefficient (ADC) measurement using diffusion-weighted imaging (DWI) has the potential to be used as an imaging biomarker for liver fibrosis assessment. In this study, we investigated the usefulness of liver ADC normalization using the spleen as a reference organ in liver fibrosis staging with 66 patients who underwent liver magnetic resonance imaging (MRI), transient elastography (TE), and surgical resection of a hepatic mass. ADC values of the liver (ADC(liver)) and spleen were analyzed, and the spleen was used for ADC(liver) normalization (nADC(liver)). ADC(liver) showed a weak negative correlation with TE (r = −0.246; p = 0.047) and fibrosis stage (r = −0.269; p = 0.029), while n ADC(liver) showed a moderate negative correlation with TE (r = −0.504; p < 0.001) and fibrosis stage (r = −0.579; p < 0.001). AUC values for nADC(liver) (0.777–0.875) were higher than those for ADC(liver) for each stage of fibrosis (0.596–0.713, p = 0.037–0.157). AUC values for TE (0.726–0.884) and nADC(liver) were not statistically different. In conclusion, normalized liver ADC can be useful in diagnosing liver fibrosis stage in patients with variable DWI acquisitions. MDPI 2019-08-28 /pmc/articles/PMC6787628/ /pubmed/31466404 http://dx.doi.org/10.3390/diagnostics9030107 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Shin, Min Ki Song, Ji Soo Hwang, Seung Bae Hwang, Hong Pil Kim, Young Jun Moon, Woo Sung Liver Fibrosis Assessment with Diffusion-Weighted Imaging: Value of Liver Apparent Diffusion Coefficient Normalization Using the Spleen as a Reference Organ |
title | Liver Fibrosis Assessment with Diffusion-Weighted Imaging: Value of Liver Apparent Diffusion Coefficient Normalization Using the Spleen as a Reference Organ |
title_full | Liver Fibrosis Assessment with Diffusion-Weighted Imaging: Value of Liver Apparent Diffusion Coefficient Normalization Using the Spleen as a Reference Organ |
title_fullStr | Liver Fibrosis Assessment with Diffusion-Weighted Imaging: Value of Liver Apparent Diffusion Coefficient Normalization Using the Spleen as a Reference Organ |
title_full_unstemmed | Liver Fibrosis Assessment with Diffusion-Weighted Imaging: Value of Liver Apparent Diffusion Coefficient Normalization Using the Spleen as a Reference Organ |
title_short | Liver Fibrosis Assessment with Diffusion-Weighted Imaging: Value of Liver Apparent Diffusion Coefficient Normalization Using the Spleen as a Reference Organ |
title_sort | liver fibrosis assessment with diffusion-weighted imaging: value of liver apparent diffusion coefficient normalization using the spleen as a reference organ |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787628/ https://www.ncbi.nlm.nih.gov/pubmed/31466404 http://dx.doi.org/10.3390/diagnostics9030107 |
work_keys_str_mv | AT shinminki liverfibrosisassessmentwithdiffusionweightedimagingvalueofliverapparentdiffusioncoefficientnormalizationusingthespleenasareferenceorgan AT songjisoo liverfibrosisassessmentwithdiffusionweightedimagingvalueofliverapparentdiffusioncoefficientnormalizationusingthespleenasareferenceorgan AT hwangseungbae liverfibrosisassessmentwithdiffusionweightedimagingvalueofliverapparentdiffusioncoefficientnormalizationusingthespleenasareferenceorgan AT hwanghongpil liverfibrosisassessmentwithdiffusionweightedimagingvalueofliverapparentdiffusioncoefficientnormalizationusingthespleenasareferenceorgan AT kimyoungjun liverfibrosisassessmentwithdiffusionweightedimagingvalueofliverapparentdiffusioncoefficientnormalizationusingthespleenasareferenceorgan AT moonwoosung liverfibrosisassessmentwithdiffusionweightedimagingvalueofliverapparentdiffusioncoefficientnormalizationusingthespleenasareferenceorgan |